Atlas Trials

Study to Evaluate a Single Dose of Apixaban in Pediatric Participants at Risk for a Thrombotic Disorder

Clinical trial NCT01707394 · COMPLETED

Trial details

NCT number
NCT01707394
Sponsor
Bristol-Myers Squibb
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Thromboembolism
Start date
2013-01-10
Primary completion
2020-06-30
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.